Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination

• Status: Completed
• Trial end date: 2010-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine the ocular hypotensive effect of Bimatoprost and the potential additional effect of the Bimatoprost/Timolol fixed combination in eyes with ocular hypertension, primary open angle glaucoma or exfoliation glaucoma.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Larissa University Hospital
• Treatments: Bimatoprost; Timolol

Criteria

Inclusion Criteria:

• Primary open angle glaucoma

• Exfoliation glaucoma

• Ocular hypertension

Exclusion Criteria:

• Younger than 18 years old

• Inability to understand and/or follow study requirements

• Women of childbearing potential not using reliable birth control, pregnant or lactating women

• History of chronic obstructive pulmonary disease, heart failure, 2nd or 3rd AV block

• Anticipated modification of treatment for systemic hypertension during the study period

• History of ocular herpes, corneal scarring, conventional or laser surgery or macular pathology

• History of allergy, poor tolerability or poor response to study medication

• Best corrected visual acuity less than 0.4

• Significant visual field defect (MD<15.0 dB)